Elective hand surgery and concomitant corticosteroid injection: Confirming increased infection risk using A national dataset

IF 0.6 Q4 SURGERY Surgery in practice and science Pub Date : 2024-09-04 DOI:10.1016/j.sipas.2024.100259
Benjamin J. Kirby , Jashvant Poeran , Nicole Zubizarreta , Daniel A. London
{"title":"Elective hand surgery and concomitant corticosteroid injection: Confirming increased infection risk using A national dataset","authors":"Benjamin J. Kirby ,&nbsp;Jashvant Poeran ,&nbsp;Nicole Zubizarreta ,&nbsp;Daniel A. London","doi":"10.1016/j.sipas.2024.100259","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Recent studies demonstrate a link between corticosteroid injection and surgical complications when procedures occur shortly after steroid administration. These publications focus on single procedures like carpal tunnel release. This study seeks to demonstrate how surgical site infection risk changes across thirteen common elective hand procedures when steroid injection is performed contemporaneously.</p></div><div><h3>Methods</h3><p>The Truven MarketScan® database identified patients who had undergone elective hand surgery between 2015 and 2016. Two cohorts were created based on the administration, or absence thereof, of contemporaneous corticosteroid injection. The primary outcome measure was infection within 30 days of surgery as measured by antibiotic prescription or repeat surgical intervention. Multivariate logistic regression was performed to assess the association between concomitant corticosteroid injections and post-operative infections while controlling for demographics and comorbidities.</p></div><div><h3>Results</h3><p>149,689 patients underwent elective hand surgery. 6104 (4.1 %) received concomitant corticosteroid injection and 14,070 (9.4 %) received post-operative antibiotics or underwent secondary surgical intervention for infection. Treatment for post-operative infection was significantly higher in the corticosteroid group (10.2 % versus 9.3 %; <em>p</em> = 0.02) driven by difference in severe infection requiring surgical intervention (3.7 % versus 3.1 %; <em>p</em> = 0.03). This finding persisted when controlling for demographics and comorbidities with adjusted OR of 1.10 (CI 1.01–1.20) for all infections and 1.16 (CI 1.01–1.33) for severe infections.</p></div><div><h3>Discussion</h3><p>These results support prior findings that patients undergoing concurrent steroid injections and surgery have increased rates of infectious complications though the absolute risk remains small. Limitations of the database preclude further investigation into the details of each procedure (e.g. ipsilateral vs contralateral injection, peri-operative antibiotics) which may impact infection rates.</p></div><div><h3>Conclusions</h3><p>Concomitant steroid injection with elective hand surgery may increase the risk of postoperative infection, particularly severe infection. However, that relative increase lies between 1 and 33 percent and should be weighed against the benefit from intraoperative corticosteroid administration.</p></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"19 ","pages":"Article 100259"},"PeriodicalIF":0.6000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666262024000263/pdfft?md5=0debdc49054f364b7afd4a6897e1b558&pid=1-s2.0-S2666262024000263-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery in practice and science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666262024000263","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Recent studies demonstrate a link between corticosteroid injection and surgical complications when procedures occur shortly after steroid administration. These publications focus on single procedures like carpal tunnel release. This study seeks to demonstrate how surgical site infection risk changes across thirteen common elective hand procedures when steroid injection is performed contemporaneously.

Methods

The Truven MarketScan® database identified patients who had undergone elective hand surgery between 2015 and 2016. Two cohorts were created based on the administration, or absence thereof, of contemporaneous corticosteroid injection. The primary outcome measure was infection within 30 days of surgery as measured by antibiotic prescription or repeat surgical intervention. Multivariate logistic regression was performed to assess the association between concomitant corticosteroid injections and post-operative infections while controlling for demographics and comorbidities.

Results

149,689 patients underwent elective hand surgery. 6104 (4.1 %) received concomitant corticosteroid injection and 14,070 (9.4 %) received post-operative antibiotics or underwent secondary surgical intervention for infection. Treatment for post-operative infection was significantly higher in the corticosteroid group (10.2 % versus 9.3 %; p = 0.02) driven by difference in severe infection requiring surgical intervention (3.7 % versus 3.1 %; p = 0.03). This finding persisted when controlling for demographics and comorbidities with adjusted OR of 1.10 (CI 1.01–1.20) for all infections and 1.16 (CI 1.01–1.33) for severe infections.

Discussion

These results support prior findings that patients undergoing concurrent steroid injections and surgery have increased rates of infectious complications though the absolute risk remains small. Limitations of the database preclude further investigation into the details of each procedure (e.g. ipsilateral vs contralateral injection, peri-operative antibiotics) which may impact infection rates.

Conclusions

Concomitant steroid injection with elective hand surgery may increase the risk of postoperative infection, particularly severe infection. However, that relative increase lies between 1 and 33 percent and should be weighed against the benefit from intraoperative corticosteroid administration.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
手部择期手术并同时注射皮质类固醇:利用全国数据集确认感染风险增加
背景最近的研究表明,在注射类固醇后不久进行手术时,皮质类固醇注射与手术并发症之间存在联系。这些文章主要针对腕管松解术等单一手术。本研究旨在证明当类固醇注射同时进行时,13 种常见手部择期手术的手术部位感染风险会发生怎样的变化。方法Truven MarketScan® 数据库识别了 2015 年至 2016 年间接受手部择期手术的患者。根据是否同时注射皮质类固醇创建了两个队列。主要结果指标是手术后 30 天内的感染,以抗生素处方或重复手术干预来衡量。在控制人口统计学和合并症的情况下,进行了多变量逻辑回归以评估同时注射皮质类固醇与术后感染之间的关系。6104人(4.1%)同时接受了皮质类固醇注射,14070人(9.4%)术后接受了抗生素治疗或因感染接受了二次手术治疗。皮质类固醇组的术后感染治疗率明显更高(10.2% 对 9.3%;P = 0.02),这是因为需要手术干预的严重感染率不同(3.7% 对 3.1%;P = 0.03)。在控制人口统计学和合并症后,这一结果仍然存在,所有感染的调整 OR 为 1.10 (CI 1.01-1.20),严重感染的调整 OR 为 1.16 (CI 1.01-1.33)。讨论这些结果支持了之前的研究结果,即同时接受类固醇注射和手术的患者感染并发症的发生率会增加,但绝对风险仍然很小。结论手部择期手术同时进行类固醇注射可能会增加术后感染的风险,尤其是严重感染。然而,这种相对增加率介于 1% 与 33% 之间,应根据术中使用皮质类固醇的益处进行权衡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
0
审稿时长
38 days
期刊最新文献
Emergency laparotomy preoperative risk assessment tool performance: A systematic review Letter to the Editor on “The pulmonary contusion score: Development of asimple scoring system for blunt lung injury” Prevalence and associated factors of acute postoperative pain in adult surgical patients: A prospective study Advances and results in omental patch repair of gastrointestinal perforations: A narrative review Practical evaluation of risk factors in patients with osteoporosis-induced thoracic and lumbar vertebral compression fractures requiring surgery
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1